Vascular Pharmacology

Papers
(The H4-Index of Vascular Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107109
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran101
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients50
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease45
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis38
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies26
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study25
Animal experimental models of ischemic limbs – A systematic review25
Graphical abstract TOC24
Graphical abstract TOC24
Biobanks: The unmet need in heart failure management24
Prevention of cardiovascular complications in elderly cancer patients21
Changes in arterial myocyte excitability induced by subarachnoid hemorrhage in a rat model21
Editorial Board20
Editorial Board20
Diabetes and vascular disease: New therapeutic avenues20
Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis20
MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension19
A random shuffle method to expand a narrow dataset: A heart failure cohort example19
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets19
0.072559118270874